Stay updated on Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial

Sign up to get notified when there's something new on the Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page. No study data, eligibility criteria, or on-page guidance were changed.
    Difference
    0.0%
    Check dated 2026-03-18T18:04:52.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    Added revision: v3.4.3 and removed revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T16:57:30.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the government funding status notice about a lapse in funding was removed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-11T09:18:05.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    A government funding/status notice was added indicating the NIH Clinical Center is open and updates regarding operating status. The page was updated to Revision: v3.4.1, replacing the previous v3.4.0 revision.
    Difference
    0.2%
    Check dated 2026-02-04T05:23:21.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated the page revision to v3.4.0. Capitalization of terms related to QC criteria and FEAR Act data has been standardized.
    Difference
    0.1%
    Check dated 2026-01-28T03:44:50.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-14T02:25:23.000Z thumbnail image

Stay in the know with updates to Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial page.